Atlas Trials

Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions

Clinical trial NCT02091739 · COMPLETED

Trial details

NCT number
NCT02091739
Sponsor
Merz Pharmaceuticals GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Troublesome SialorrheaParkinson's DiseasePost-strokeTraumatic Brain Injury
Start date
2014-04-01
Primary completion
2015-08-01
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.